Gaps in antidepressant prescribing in primary care in the United Kingdom

International Clinical Psychopharmacology

Volumn 13, Issue 6, 1998, Pages 235-243

  Hylan, T R ^a   Dunn, R L ^b   Tepner, Rosalinda G ^a   Meurgey, Francois ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MEDSTAT Group   (United States)

Author keywords

Adherence; Antidepressants; Depression; Selective serotonin reuptake inhibitors; Tricyclic antidepressants

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DATA BASE; DEPRESSION; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0031770149     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199811000-00001     Document Type: Article

References (29)

1. Agency for Health Care Policy Research (1993): Treatment of major depression: clinical practice guidelines, no. 5, vol. 2. Rockville, MD: US Department of Health and Human Services, AHCPR. Publication no. 93-0550.
2. Ashcraft MLF, Fries BE, Nerenz DR, Falcon SP, Srivastava SV, Lee CZ, et al. (1989): A psychiatric patient classification system: an alternative to diagnosis-related groups. Med Care 27:543-557.
3. Beaumont G, Baldwin D, Lader M (1996): A criticism of the practice of prescribing subtherapeutic doses of antidepressants for the treatment of depression. Hum Psychopharmacol 11:283-291.
4. Canadian Coordinating Office for Health Technology Assessment (1997): A clinical and economic evaluation of selective serotonin reuptake inhibitors in major depression. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA).
5. Cramer JA (1995): Partial medication compliance: the enigma in poor medical outcomes. Am J Managed Care 1:107-174.
6. Demyttenaere K (1997): Compliance during treatment with antidepressants. J Affect Dis 43:27-39.
7. Demyttenaere K, Van Ganse E, Gregoire J, Gaens E, Mesters P (1998): Compliance in depressed patients treated with fluoxetine and amitriptyline. Int Clin Psychopharmacol 13:11-17.
8. Donoghue JM (1996): Prescribing patterns of selective serotonin reuptake inhibitors in primary care: a naturalistic follow-up study. J Serotonin Res 4:267-270.
9. Donoghue JM, Tylee A (1996): The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168:164-168.
10. Donovan JL, Blake DR (1992): Patient noncompliance: deviance of reasoned decision-making. Soc Sci Med 34:507-513.
11. Fawcett J (1995): Compliance: definitions and key issues. J Clin Psychiatry 56 (Suppl. 1):4-10.
12. Henry ME, Moore CM, Stoddard E, Kaufman MJ, Barreira PJ, Vuckovic A, Renshaw PF (1998): Clinical changes and brain drug concentrations on the third day of substitution of placebo for SSRI treatment [abstract no. 178]. Thirty-eighth NCDEU Annual Meeting, Boca Raton, FL, June 1988.
13. Katon W, von Korff M, Lin E, Bush T, Ormel J (1992): Adequacy and duration of antidepressant treatment in primary care. Med Care 30:67-76.
14. Kramer JC, Klein DF, Fink M (1961): Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry 118:549-550.
15. Kruse W and Weber E (1990): Dynamics of drug regimen compliance - its asssessment by microprocessor-based monitoring. Eur J Clin Pharmacol 38:561-565.
16. Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, et al. (1992): Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769-773.
17. Montejo AL, Gilaberte I, Fombellida C, Hylan TR, Sacristan JA (1998): Patron de uso de los inhibidores de la recaptacion de serontonina y venlafaxina en la practica clinica. Actas Luso Espanolas de Neurologia y Psiquiatria 26:75-82.
18. Montgomery SA, Dufour H, Brion S, Baillaedrena J, Laqueille X, Ferrey G (1988): The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 153 (Suppl. 3):69-76.
19. Montgomery SA, Rasmussen JG, Lyby K, Connor P, Tanghoj P (1992): Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. Int Clin Psychopharmacol 6 (Suppl. 5):65-70.
20. Rosenbaum J, Fava M, Hoog SL, Ascroft RC, Krebs WB (1998): Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 44:77-87.
21. Simon GE, Von Korff M, Wagner EH, Barlow W (1993): Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 15:399-408.
22. Simon GE, Von Korff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH (1996): Initial antidepressant choice in primary care. effectiveness and cost of fluoxetine vs. tricyclic antidepressants. J Am Med Assoc 275:1897-1902.
23. Simon GE, Fishman P (1998): Cost implications of initial antidepressant selection in primary care. Pharmacoeconomics 13:61-70.
24. Stahl MM, Lindquist M, Pettersson M, Edwards IR, Sanderson JH, Taylor NF, et al. (1997): Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 53:163-169.
25. Steiner JF, Prochazka AV (1997): The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50:105-116.
26. Thompson C, Thompson CM (1989): The prescription of antidepressants in general practice. I. A critical review. Hum Psychopharmacol 4:91-107.
27. Thompson D, Buesching DR Gregor KJ, Oster G (1996): Patterns of antidepressant use and their relations to costs of care. Am J Managed Care 2:1239-1246.
28. Young A, Currie A, Ashten CH (1997): Antidepressant withdrawal syndrome. Br J Psychiatry 170, 288.
29. Zajecka J, Fawcett J, Amsterdam J, Quitkin F, Reimherr F, Rosenbaum J, et al. (1998): Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychapharmacol 18:193-197.